Latitude Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,613
Closed -$545K 294
2022
Q1
$545K Buy
10,613
+2,651
+33% +$137K 0.12% 166
2021
Q4
$399K Sell
7,962
-4
-0.1% -$198 0.11% 185
2021
Q3
$384K Buy
7,966
+4,118
+107% +$209K 0.12% 169
2021
Q2
$203K Buy
+3,848
New +$201K 0.15% 164
2021
Q1
Sell
-10,430
Closed -$507K 170
2020
Q4
$507K Buy
+10,430
New +$514K 0.45% 54

Other funds holding SNY

Latitude Advisors's SNY Position: Q2 2022 in Review

Latitude Advisors sold out of Sanofi (SNY) in Q2 2022, closing a stake of 10,613 shares — an estimated $545K sold.

Latitude Advisors first reported a position in SNY in Q4 2020 and held it in 5 quarters. The position peaked at $545K in Q1 2022. 656 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

  • Latitude Advisors reported no remaining Sanofi position as of Q2 2022 after selling out during the quarter.
  • Latitude Advisors sold 10,613 Sanofi shares in Q2 2022, an estimated $545K.
  • Latitude Advisors first reported a position in Sanofi in Q4 2020 and held it in 5 quarters.
  • Latitude Advisors's Sanofi position peaked at $545K in Q1 2022.
  • 656 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Latitude Advisors's 13F filing for Q2 2022, filed 28 Jul 2022.